| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 844 | - | - | 41.254 | 52.796 | 46.106 | 74.917 | 94.613 | 205.033 | 273.993 |
| Total Income - EUR | 844 | - | - | 41.254 | 52.796 | 46.106 | 74.917 | 94.613 | 205.033 | 273.993 |
| Total Expenses - EUR | 7.429 | - | - | 45.001 | 51.713 | 46.547 | 77.435 | 108.518 | 169.500 | 199.660 |
| Gross Profit/Loss - EUR | -6.585 | - | - | -3.746 | 1.083 | -442 | -2.518 | -13.905 | 35.533 | 74.332 |
| Net Profit/Loss - EUR | -6.610 | - | - | -4.159 | 576 | -1.105 | -3.267 | -15.002 | 33.483 | 63.096 |
| Employees | 1 | - | - | 0 | 5 | 4 | 6 | 6 | 11 | 7 |
Check the financial reports for the company - Valora Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.728 | - | - | 8.889 | 5.240 | 29.794 | 36.099 | 32.934 | 17.507 | 56 |
| Current Assets | 3.373 | - | - | 17.671 | 18.287 | 20.582 | 26.816 | 17.449 | 11.671 | 93.690 |
| Inventories | 2.697 | - | - | 4.526 | 8.690 | 15.854 | 26.038 | 16.636 | 0 | 0 |
| Receivables | 0 | - | - | 8.258 | 2.170 | 369 | 103 | 0 | 0 | 69.834 |
| Cash | 676 | - | - | 4.888 | 7.427 | 4.360 | 675 | 813 | 11.671 | 23.856 |
| Shareholders Funds | -6.565 | - | - | 9.400 | 9.795 | 8.504 | 5.048 | -9.938 | 23.575 | 86.539 |
| Social Capital | 45 | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 18.667 | - | - | 17.179 | 13.751 | 41.890 | 57.886 | 60.339 | 5.621 | 7.226 |
| Income in Advance | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8692 - 8692" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Valora Med Srl